This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Gabapentin in the Treatment of Aggression Associated With Conduct Disorder

Sanjay Gupta, MD; Bradford L. Frank, MD, MPH; Prakash S. Masand, MD

Published: April 1, 2000

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Selective serotonin reuptake inhibitors (SSRIs) are the mainstay of treatment for a wide variety of psychiatric disorders including mood and anxiety disorders. Hair loss with the SSRIs, tricyclic antidepressants (TCAs), and other classes of antidepressants has been anecdotally reported.1-6 We report a case of a 50-year-old white woman with bipolar disorder who developed hair loss while taking the SSRI citalopram.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 2

Quick Links: Impulse-Control Disorders , Violence and Aggression

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...